contact us  chinese
shanghai newsummit biopharma
business solutions
core business

core business model

key products

core competitive advantages

core competitive advantages
& industry status

newsummit cro service network

company profile

we are a leading china-based new drug development process solutions provider. our main business is to provide professional technology service for new drug research and development. through collabo-ration with five state high tech clusters and integration of upstream and downstream suppliers, we establish the platform of chain r&d (pcrd) by offering a full range of services for new drug r&d.

we set up a modularized, standardized and industrialized pipeline system to provide good research and development practices (grdp) for new drug r&d, including: pre-clinical new drug research service focusing on pharmacology and toxicology research (ind-cro);phase i, ii and iii clinical studies and pilot-scale up studies (nda-cro); international multi-center clinical research service and international clinical phase i/ii studies after completing sfda ii a clinical studies(fda/emea-cro); research and registration services on medical devices, diagnostics, medical equipment; during their new drug development process, our value-added services will provide clients with opportunities to access additional funding, such as government research grants and private investment......

·  shanghai newsummit biopharma successfully held "scientific action ...
·  the ind sumbission of of biological new drug (category i)"zd55-il-...
·  the inauguration of national science and technology enterprise inc...
·  warm congratulations to wuhan biolake new drug incubation public s...
·  china torch program-pcrd platform passed the acceptance test...
address: 2f,no.780,cailun road,zhangjiang high technology park,shanghai city,china
tel: +86-21-50798788-8032
fax: +86-21-50798788-8088
email: [email protected]

u.s. bio

copyright(c)2016,shanghai newsummit biopharma all rights reserved.  supported by information center